Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer

PURPOSE: Reovirus propagates with high efficiency in KRAS mutated colorectal cancer (CRC). About 45–50% of CRC patients possess a KRAS mutation. Oncolytic reovirus treatment in combination with chemotherapy was tested in patients possessing KRAS mutated metastatic CRC. This study evaluates the biolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogel, Elisha J, Samouha, Avishai, Goel, Sanjay, Maitra, Radhashree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407676/
https://www.ncbi.nlm.nih.gov/pubmed/34475783
http://dx.doi.org/10.2147/CMAR.S324203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407676/
https://www.ncbi.nlm.nih.gov/pubmed/34475783
http://dx.doi.org/10.2147/CMAR.S324203

Ejemplares similares